Elderly patients with advanced colorectal cancer derive similar benefit without excessive toxicity after first-line chemotherapy with oxaliplatin-based combinations: comparative outcomes from the 03-TTD-01 phase III study.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples